Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/forge/gxpi.com/web/wp/wp-includes/pomo/plural-forms.php on line 210

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/forge/gxpi.com/web/app/plugins/wordfence/models/block/wfBlock.php on line 536

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/forge/gxpi.com/web/app/plugins/wordfence/models/block/wfBlock.php on line 537

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/forge/gxpi.com/web/app/plugins/wordfence/models/block/wfBlock.php on line 539

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/forge/gxpi.com/web/app/plugins/wordfence/models/block/wfBlock.php on line 554

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/forge/gxpi.com/web/app/plugins/wordfence/models/block/wfBlock.php on line 557
Formpipe.GxP | Data Integrity

Key Benefits

Focus

Put simply, our team will work with you to establish what your business needs to prioritise, in respect of maintaining data integrity and how to achieve this. We can manage the auditing of your third-party service providers where there is shared responsibility for maintaining integrity of records.

Discretion

Sometimes things go wrong and urgent remediation action is needed. Our trusted and proven team are able to work swiftly, discretely and effectively between your organisation and regulatory authorities when there has been a suspected or actual data integrity breach.

Understanding Data Preservation

How do you preserve the integrity of your data from many systems, including some file types no longer supported, for the duration of time needed to satisfy the regulators and still be able to search it and read it? Simple. Ask us.

Related Files

“We have worked with Formpipe over several years for FDA and EU regulated product validation and remediation activities, and their discretion and pragmatism have been invaluable.”
Head, Global Technical Operations, Novartis Vaccines & Diagnostics